Prediction of Human Pharmacokinetics in 2013 and Beyond

被引:6
作者
Houston, J. Brian [1 ]
机构
[1] Univ Manchester, Manchester Pharm Sch, Ctr Appl Pharmacokinet Res, Manchester M13 9PT, Lancs, England
关键词
DISPOSITION; METABOLISM;
D O I
10.1124/dmd.113.055376
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The utility of in vitro generated kinetic data to provide quantitative prediction of in vivo pharmacokinetic behavior is well established and forms a cornerstone of many research projects in drug metabolism and disposition, particularly within the pharmaceutical industry. This issue provides several excellent examples of the use of in vitro techniques for prediction of human pharmacokinetics (PK). The general area of in vitro-in vivo extrapolation (IVIVE) is broad and hence the spectrum of topics covers various aspects drug clearance and distribution and drug-drug interactions. Some articles were commissioned whereas others were identified during the reviewing process. Overall they provide a snapshot of activity at the end of 2013. They document that whereas the translation of some in vitro approaches is now established, other areas are in their infancy and need more development.
引用
收藏
页码:1973 / 1974
页数:2
相关论文
共 17 条
  • [1] Heterotropic Activation of the Midazolam Hydroxylase Activity of CYP3A by a Positive Allosteric Modulator of mGlu5: In Vitro to In Vivo Translation and Potential Impact on Clinically Relevant Drug-Drug Interactions
    Blobaum, Anna L.
    Bridges, Thomas M.
    Byers, Frank W.
    Turlington, Mark L.
    Mattmann, Margrith E.
    Morrison, Ryan D.
    Mackie, Claire
    Lavreysen, Hilde
    Bartolome, Jose M.
    MacDonald, Gregor J.
    Steckler, Thomas
    Jones, Carrie K.
    Niswender, Colleen M.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Stauffer, Shaun R.
    Daniels, J. Scott
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2066 - 2075
  • [2] Drug Metabolites as Cytochrome P450 Inhibitors: A Retrospective Analysis and Proposed Algorithm for Evaluation of the Pharmacokinetic Interaction Potential of Metabolites in Drug Discovery and Development
    Callegari, Ernesto
    Kalgutkar, Amit S.
    Leung, Louis
    Obach, R. Scott
    Plowchalk, David R.
    Tse, Susanna
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2047 - 2055
  • [3] Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac
    Chan, Tom S.
    Yu, Hongbin
    Moore, Amanda
    Khetani, Salman R.
    Tweedie, Donald
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2024 - 2032
  • [4] A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development
    Di, Li
    Feng, Bo
    Goosen, Theunis C.
    Lai, Yurong
    Steyn, Stefanus J.
    Varma, Manthena V.
    Obach, R. Scott
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 1975 - 1993
  • [5] In Vitro-In Vivo Correlation for Low-Clearance Compounds Using Hepatocyte Relay Method
    Di, Li
    Atkinson, Karen
    Orozco, Christine C.
    Funk, Carrie
    Zhang, Hui
    McDonald, Thomas S.
    Tan, Beijing
    Lin, Jian
    Chang, Cheng
    Obach, R. Scott
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2018 - 2023
  • [6] Frederick CB, 2012, CLIN PHARMACOL THER, V87, P345
  • [7] Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data
    Jones, Hannah M.
    Barton, Hugh A.
    Lai, Yurong
    Bi, Yi-an
    Kimoto, Emi
    Kempshall, Sarah
    Tate, Sonya C.
    El-Kattan, Ayman
    Houston, J. Brian
    Galetin, Aleksandra
    Fenner, Katherine S.
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (05) : 1007 - 1017
  • [8] Utility of In Vitro Systems and Preclinical Data for the Prediction of Human Intestinal First-Pass Metabolism during Drug Discovery and Preclinical Development
    Karlsson, Fredrik H.
    Bouchene, Salim
    Hilgendorf, Constanze
    Dolgos, Hugues
    Peters, Sheila Annie
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2033 - 2046
  • [9] In Vitro P-glycoprotein Efflux Ratio Can Predict the In Vivo Brain Penetration Regardless of Biopharmaceutics Drug Disposition Classification System Class
    Kikuchi, Ryota
    de Morais, Sonia M.
    Kalvass, J. Cory
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2012 - 2017
  • [10] Stereoselective Inhibition of CYP2C19 and CYP3A4 by Fluoxetine and Its Metabolite: Implications for Risk Assessment of Multiple Time-Dependent Inhibitor Systems
    Lutz, Justin D.
    VandenBrink, Brooke M.
    Babu, Katipudi N.
    Nelson, Wendel L.
    Kunze, Kent L.
    Isoherranen, Nina
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2056 - 2065